TrialAntimicrobial agents and chemotherapy2016

Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers.

Jeremy J Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.